Breast Lesion Localization Methods Market Size and Share Analysis Report: Forecast Trends and Outlook (2026-2035)

Breast Lesion Localization Methods: Introduction

A breast lesion refers to the presence of an abnormal tissue or lump in the breast area. It can be a single or cluster of lumps. Although most lesions are benign (non-cancerous), some might turn out to be malignant (cancerous), hence, early detection is highly imperative. Symptoms for benign breast lesion may include pain in the affected area, fatigue, discomfort or loss of weight and appetite. Whereas changes in breast size, swelling or hardened area inside the underarm or breast are common indicators of malignant breast lesions.

Locating these lesions is extremely crucial in order to get a timely treatment. A breast lesion can be found through a self or clinical exam, which can be later confirmed using an imaging test. Diagnostic methods commonly constitute mammograms, magnetic resonance imaging (MRI), computed tomography (CT) scans, and ultrasounds.

Breast Lesion Localization Methods Market Analysis

With the rising prevalence of breast cancer, the number of surgeries has been on a rise. When compared to mastectomy, the frequency of breast-conserving (lumpectomy) surgery is higher. This is because it only removes the area of tumour and allows faster recovery as well. Since, these tumours are non-palpable, they require localization, which can be done through an ultrasound or mammography. As a result, the breast lesion localization methods market value has increased over the years.

Over the years, wire guided localization (WGL) has been commonly used for the surgical excision of a non-palpable breast lesion. This can be accredited to its low cost, high efficacy, and ease of accessibility. However, owing to several logistical challenges like its placement, patient discomfort and a possibility of wire dislocation, breast surgeons have showed their preference for other techniques like radioactive seed localization, radio-occult lesion localization (ROLL), and intraoperative ultrasound. As a result, the market for breast lesion localization has been evolving and welcoming new developments.

New localization devices like SAVI SCOUT®, Localizer™, Molli™, Magseed®, EnVisio®, and Pintuition® have flourished the market. MELODY (Methods for Localization of Different types of breast lesions) is another initiative launched by the European Breast Cancer Research Association of Surgical Trialists and the iBRA-NET. It allows the study of breast localization techniques and devices from various perspectives by enrolling a cohort of breast cancer patients, undergoing breast-conserving surgery using imaging-guided localization. Such initiatives indicate that we can observe breast lesion localization methods market growth in the upcoming years.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Breast Lesion Localization Methods Market Segmentation

Breast Lesion Localization Methods Market Overview

The occurrence of breast cancer has been more common than lung cancer. Approximately, 297,790  women in the United States alone are estimated to be diagnosed with lung cancer in 2024. As a result, Unites States holds the largest breast lesion localization methods market share. With a high-tech infrastructure and the presence of major universities and healthcare industry pioneers, there has been significant emphasis on bringing quality diagnostics and treatments for the patients. Moreover, WHO recently released a Global Breast Cancer Initiative Framework that provides a roadmap to save around 2.5 million  lives from breast cancer by 2040.

In addition, India partnered with the United States to develop an artificial intelligence (AI)-enabled digital pathology platform that will enable better diagnosis and prediction of therapeutic benefits to the patients. The US-India cancer dialogue also aims to bring the public and private sector that envisions around data sharing and synthetic biology.

Breast Lesion Localization Methods Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Boston Scientific Corporation

• BD

• Medtronic

• Abbott

• Cook

• Stryker

• Wright Medical Group N.V.

• Zimmer Biomet

• Smith+Nephew

• Boston Scientific Corporation

• Organogenesis Inc.

• Arthrex, Inc.

• Orthofix Medical Inc.

• Kubtec X-Ray

• Miltenyi Biotec GMBH

• Naviscan

• PerkinElmer Inc.

• Thermo Fisher Scientific, Inc.

• Merit Medical Systems